MEDINET Co., Ltd. (TYO:2370)

Market Cap	7.77B -5.3%
Revenue (ttm)	998.00M -41.4%
Net Income	-3.05B
EPS	-26.77
Shares Out	277.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	737,500
Open	28.00
Previous Close	28.00
Day's Range	27.00 - 29.00
52-Week Range	27.00 - 43.00
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2026

About MEDINET

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers valu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 92
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2370

Financial Performance

In fiscal year 2018, MEDINET's revenue was 998.00 million, a decrease of -41.43% compared to the previous year's 1.70 billion. Losses were -3.05 billion, 17.1% more than in 2017.